High-risk primary prevention
Is statin-modified reduction in lipids the most important preventive therapy for cardiovascular disease? A pro/con debate
8
Economic evaluation of statins in high-risk patients treated for primary and secondary prevention of cardiovascular disease in Greece
9
Is carotid artery evaluation necessary for primary prevention in asymptomatic high-risk patients without atherosclerotic cardiovascular disease?
9
Tranexamic Acid versus Placebo for Prevention of Primary Postpartum Haemorrhage among High Risk Women Undergoing Caesarean Section in Abakaliki: A Randomized Controlled Trial
9
Primary prevention of psychosis through interventions in the symptomatic prodromal phase, a pragmatic Norwegian Ultra High Risk study
9
Risk Factors and Primary Prevention Trials for Type 1 Diabetes
14
Preventing Stroke Among Children With Sickle Cell Anemia: An Analysis of Strategies That Involve Transcranial Doppler Testing and Chronic Transfusion
12
Practical use of the Framingham risk score in primary prevention
7
Primary prevention of coronary heart disease: integration of new data, evolving views, revised goals, and role of rosuvastatin in management. A comprehensive survey
56
The Use of Statins in Pediatrics: Knowledge Base, Limitations, and Future Directions
13
Long term safety and efficacy of lowering low density lipoprotein cholesterol with statin therapy : 20 year follow up of West of Scotland Coronary Prevention Study
8
The Good Skin Care Practices and Emollient Use since Early Infancy as the Primary Prevention of Infantile Atopic Dermatitis among Infants at Risk: a Randomized Controlled Trial
6
Systematic versus opportunistic risk assessment for the primary prevention of cardiovascular disease
12
Comparison of Fondaparinux and Enoxaparin in Non-ST Elevation Acute Coronary Syndrome.
81
ASPIRIN USAGE FOR EARLY DETERRENCE OF CARDIOVASCULAR ATTACK
10
New insights into the mechanisms of action of aspirin and its use in the prevention and treatment of arterial and venous thromboembolism
8
Consensus Report: Diabetes Performance Measures: Current Status and Future Directions
11
Frequency of malaria and glucose 6 phosphate dehydrogenase deficiency in Tajikistan
8
Informing the prevention, diagnosis and management of acute rheumatic fever and rheumatic heart disease in Aboriginal Australian and Torres Strait Islander populations
272
SERUM LIPOPROTEIN COMPONENTS IN ISCHEMIC CEREBROVASCULAR STROKE PATIENTS
7